On this page

New to Peptides?

Start with our Peptide 101 guide to understand the basics before diving in.

PEPTIDE CATEGORY

Retatrutide

Triple Hormone Receptor Agonist Peptide

Retatrutide is a investigational peptide that targets three hormone receptors involved in metabolic regulation and appetite control it is currently being studied for its potential role in weight management and metabolic heath.


Overview

What is it?

Retatrutide is an advanced, next-generation peptide known as a “triple-agonist,” specifically designed to target three separate metabolic pathways: GLP-1, GIP, and Glucagon receptors.

How does it work?

This compound takes metabolic enhancement to the absolute absolute max. While GLP-1 and GIP handle profound appetite suppression and insulin optimization, the addition of the Glucagon receptor directly revs up your resting energy expenditure—essentially telling your body to burn more calories even while you rest.

What is it good for?

  • Overcoming stubborn weight loss plateaus that other compounds couldn’t break.
  • Actively increasing your basal metabolic rate (BMR) to burn fat faster.
  • Rapidly clearing fat accumulations in liver tissue.

Summary (Pros and Cons)

Pros: Currently showing the highest weight loss percentages ever recorded in clinical trial history; actively boosts metabolism rather than just cutting food intake.

Cons: Can cause a temporary elevated resting heart rate; still in the later phases of global clinical trials.

General Overview

Retatrutide is the absolute cutting edge of metabolic science, earning it the nickname “Triple G.” By combining appetite control with an active metabolic accelerator, it represents a massive leap forward for anyone dealing with profound metabolic slow-downs.


Research Area

Retatrutide is a investigational peptide that targets three hormone receptors involved in metabolic regulation and appetite control it is currently being studied for its potential role in weight management and metabolic heath.

At a Glance

Research Status

in Clinical Trials

Molecular Weight

-4,759 Da

Half-Life

-no Hours (Estimated)

Administrator

Injectable (Subcutaneous)

Regulatory Status

Not Approved

Antimanual

Ask our AI support assistant your questions about our platform, features, and services.

You are offline
Chatbot Avatar
What can I help you with?
×